Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,079Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Epclusa

02 1Vosevi

PharmaCompass

01

Brand Name : Epclusa

Velpatasvir

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Epclusa

arrow
Medlab Asia & Asia Health
Not Confirmed

Velpatasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 1,462

2020 Revenue in Millions : 1,599

Growth (%) : -9

blank

02

Brand Name : Epclusa

Velpatasvir

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Epclusa

arrow
Medlab Asia & Asia Health
Not Confirmed

Velpatasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 1,570

2021 Revenue in Millions : 1,462

Growth (%) : 7

blank

03

Brand Name : Epclusa

Velpatasvir

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Epclusa

arrow
Medlab Asia & Asia Health
Not Confirmed

Velpatasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 1,537

2022 Revenue in Millions : 1,530

Growth (%) : 0

blank

04

Brand Name : Vosevi

Velpatasvir

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Vosevi

arrow
Medlab Asia & Asia Health
Not Confirmed

Velpatasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 257

2018 Revenue in Millions : 396

Growth (%) : -35

blank